0R15 8520.0 0.0% 0R1E 8203.0 0.0% 0M69 21090.0 67.5139% 0R2V 226.02 9878.8079% 0QYR None None% 0QYP 412.97 -2.8306% 0RUK 2652.0 -9.2402% 0RYA 1554.0 -0.7029% 0RIH 174.55 -1.3563% 0RIH 165.15 -5.3853% 0R1O 198.5 9800.2494% 0R1O None None% 0QFP None None% 0M2Z 267.777 -0.1763% 0VSO 32.05 -9.9846% 0R1I None None% 0QZI 559.0 0.7207% 0QZ0 220.0 0.0% 0NZF None None% 0YXG 165.7358 2.7149%

Artificial Intelligence and Emerging Technologies Report

Two Artificial Intelligence Stocks Showcasing Growth Opportunities – PME, APX

Apr 24, 2024

PME:ASX
Investment Type
Large-cap
Risk Level
Action
Rec. Price (AU$)
APX:ASX
Investment Type
Small-Cap
Risk Level
Action
Rec. Price (AU$)

This report is an updated version of the report published on the 24 April 2024 at 2:07 PM AEST.

Company Overview: Overview: Pro Medicus Limited (ASX: PME) is a health imaging IT provider that develops and supplies healthcare imaging software and services to hospitals, diagnostic imaging groups and other related health entities in Australia, Europe, and North America. Appen Limited (ASX: APX) is a technology company enabling organisations to launch artificial intelligence (AI) systems. The company has more than 25 years of experience in data sourcing, data annotation, and model evaluation. Its products and services aid governments as well as players in the technology, automotive, financial services, retail, and healthcare space. This Global Artificial Intelligence & Emerging Technologies Report covers the Company Overview & Price performance, Summary table, Key positives & negatives, Key metrics, Company details, technical guidance & Stock recommendation, and Price chart.



Section 1.0: Key Metrics in Pictures

 
Having looked at the key financial metrics above the below sections provide in-depth fundamental, and technical analysis on this Health Care Technology Business along with recommendation, technical support, and resistance level & indicative stop-loss.

Section 2.0: Pro Medicus Limited (‘Buy’ at AUD 108.130 current market price per share as on 24 April 2024)

2.1 Company Details

2.2 Valuation, Technical Summary & Stock Recommendation

The stock has increased by ~8.2% in last one month, and over the last three months, it has moved up by ~7.38%. The stock has a 52-week low and 52-week high of AUD 58.600 and AUD 111.885, respectively and is currently trading above the 52-week high-low average. PME was last covered in a report dated ’02 November 2022’.

Appen Limited (ASX: APX)

Section 3.0: Key Metrics in Pictures

Having looked at the key financial metrics above the below sections provide in-depth fundamental, and technical analysis on this Technology Stock along with recommendation, technical support, and resistance level & indicative stop-loss.

Section 4.0: Appen Limited (ASX: APX) (‘Speculative Buy’ at AUD 0.700 current market price per share as on 24 April 2024)

4.1 Company Details

4.2 Valuation, Technical Summary & Stock Recommendation

The stock has decreased by ~21% in last six months, and over the last nine months, it has moved down by ~65%. The stock has a 52-week low and 52-week high of AUD 0.260 and AUD 3.602, respectively and is currently trading below the 52-week high-low average. APX was last covered in a report dated ’18 March 2024’.

Markets are trading in a highly volatile zone currently due to certain macro-economic issues and geopolitical issues prevailing geopolitical tensions. Therefore, it is prudent to follow a cautious approach while investing.

Note 1: Past performance is neither an Indicator nor a guarantee of future performance.

Note 2: The reference date for all price data, currency, technical indicators, support, and resistance levels is 24 April 2024. The reference data in this report has been partly sourced from REFINITIV.

Note 3: Investment decisions should be made depending on an individual’s appetite for upside potential, risks, holding duration, and any previous holdings. An ‘Exit’ from the stock can be considered if the Target Price mentioned as per the Valuation and or the technical levels provided has been achieved and is subject to the factors discussed above.

Note 4: Dividend Yield may vary as per the stock price movement.

Technical Indicators Defined: -

Support: A level at which the stock prices tend to find support if they are falling, and a downtrend may take a pause backed by demand or buying interest. Support 1 refers to the nearby support level for the stock and if the price breaches the level, then Support 2 may act as the crucial support level for the stock.

Resistance: A level at which the stock prices tend to find resistance when they are rising, and an uptrend may take a pause due to profit booking or selling interest. Resistance 1 refers to the nearby resistance level for the stock and if the price surpasses the level, then Resistance 2 may act as the crucial resistance level for the stock.

Stop-loss: It is a level to protect further losses in case of unfavourable movement in the stock prices.


Disclaimer-

References to ‘Kalkine’, ‘we’, ‘our’ and ‘us’ refer to Kalkine Limited.

This website is a service of Kalkine Limited. Kalkine Limited is a private limited company, incorporated in England and Wales with registration number 07903332. Kalkine Limited is authorised and regulated by the Financial Conduct Authority under reference number 579414.

The article has been prepared for informational purposes only and is not intended to be used as a complete source of information on any particular company. No advice or information, whether oral or written, obtained by you from Kalkine or through or from the service shall create any warranty not expressly stated. Kalkine does not intend to exclude any liability which it is not permitted to exclude under applicable law or regulation.

Kalkine does not offer financial advice based upon your personal financial situation or goals, and we shall NOT be held liable for any investment or trading losses you may incur by using the opinions expressed in our publications, market updates, news alerts and corporate profiles. Kalkine does not intend to exclude any liability which it is not permitted to exclude under applicable law or regulation. Kalkine’s non-personalised advice does not in any way endorse or recommend individuals, investment products or services for your personal financial situation. You should discuss your portfolios and the risk tolerance level appropriate for your personal financial situation, with a professional authorised financial planner and adviser. You should be aware that the value of any investment and the income from it can go down as well as up and you may not get back the amount invested.

Kalkine Media Limited, an affiliate of Kalkine Limited, may have received, or be entitled to receive, financial consideration in connection with providing information about certain entity(s) covered on its website.

We use cookies to help us improve, promote, and protect our services. By continuing to use this site, we assume you consent to our Cookies Policy. For more information, read our Privacy Policy and Terms and Conditions